Synaptogenix (SNPX) Completes Rebranding to TAO Synergies (TAOX) Jul 1, 2025 09:16AM
Synaptogenix (SNPX) Rebrands as TAO Synergies (TAOX) Jun 26, 2025 09:15AM
Synaptogenix (SNPX) Announces Initial TAO Acquisition under Crypto Treasury Strategy, Appoints BitGo as Custodian Jun 24, 2025 09:15AM
Synaptogenix (SNPX) Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength Dec 20, 2024 09:15AM
Synaptogenix (SNPX) Files for 11.93M Share Offering by Selling Stockholders Oct 10, 2024 05:16PM


Sep 11, 2024 09:00AM Synaptogenix (SNPX) Announces $5.0 Million Financing
Jul 18, 2024 09:04AM Synaptogenix (SNPX) Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in Spinal Cord Injury
Jun 26, 2024 09:01AM Synaptogenix (SNPX) Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1